-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Tenet Healthcare, Lowers Price Target to $208

Benzinga·07/24/2025 12:11:03
Listen to the news
Barclays analyst Andrew Mok maintains Tenet Healthcare (NYSE:THC) with a Overweight and lowers the price target from $215 to $208.